Search

everythinglearnresearchcommunity

for

Search:↓

Pediatric androgenetic alopecia is linked to obesity, family history, hormonal imbalances, and requires personalized treatment including managing comorbidities.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

The case suggests that dissecting cellulitis of the scalp can occur in a White child and should be considered when diagnosing pediatric scarring alopecia.

Methotrexate may effectively and safely treat hair loss in children, with notable improvement after 12-15 months.

An 8-year-old with severe hair loss regrew all hair after six months of tofacitinib treatment.

Iodine is crucial for health, environments affect heart rates, holistic health is important, pediatric health is reviewed, sinus septa complicate dental work, and new lipid carriers may improve hair loss treatments.

Calcium supplements improved bone deformities but not skin papules or hair loss.

A 15-year-old boy was correctly diagnosed with a rare skin condition after initially being misdiagnosed.

Children with autoimmune hair loss have similar vitamin D levels to healthy kids, suggesting no extra screening is needed.

Early detection and treatment are crucial to prevent permanent hair loss in children with pressure alopecia.

A 10-year-old girl with hair and eyelash loss showed significant regrowth after treatment.

Poor nutrition is linked to increased hair loss in Canadian children.

Avoid tight hairstyles and use minoxidil to prevent and treat hair loss in young Sikh boys.

Low-dose oral minoxidil improved hair growth in most pediatric patients with mild side effects.

Most children with alopecia areata have patchy hair loss and common trichoscopic features like yellow and black dots.

A 14-year-old girl with severe hair loss regrew her hair using upadacitinib.

Upadacitinib successfully treated a child's severe skin and hair loss issues.

Platelet-rich plasma is effective and safe for treating hair loss in kids.

Most children with alopecia areata improved with treatment, but those with more hair loss had worse outcomes.

A new drug, abrocitinib, helped a child with severe hair loss regrow hair.

The treatment is effective and safe for severe alopecia areata in children, but not for total or universal hair loss.

The study has limitations, and future research should use better methods to improve treatment for children with hair loss.

Children generally have milder SARS symptoms than adults, with good outcomes and no deaths reported, but long-term effects are unclear.

Most children with CNS tumors on targeted therapy had skin reactions, which were generally treatable without stopping the therapy.

High-dose mizoribine effectively controls symptoms in adolescents with lupus while reducing steroid use, with manageable side effects.

Stopping the use of fluocinolone oil containing balsam fragrance improved hair regrowth in children allergic to it.

Trichoscopy is crucial for diagnosing rare genetic hair disorders.

A multidisciplinary approach is crucial for treating complex cases of Rapunzel syndrome in children.

Endocrine diseases in children can cause various skin and hair changes.

Scalp micropigmentation is a non-surgical alternative to hair transplants that mimics hair follicles and requires no downtime.